IBR5 (Indole-3-Butyric Acid Response 5) is a dual-specificity MAPK phosphatase in Arabidopsis thaliana that regulates auxin and abscisic acid (ABA) signaling, as well as plant defense responses . The IBR5 protein, encoded by the IBR5 gene (At2g04550), plays a critical role in modulating phytohormone pathways by dephosphorylating signaling components . Its discovery and functional characterization have relied heavily on molecular biology tools, including the development of specific antibodies for protein detection.
The IBR5 antibody was first described in a 2003 study as a polyclonal antibody raised against the IBR5 protein . This antibody was used in immunoblot assays to confirm the presence and size of IBR5 in wild-type plants and its absence in the ibr5-1 mutant, which harbors a premature stop codon . Key findings from its application include:
| Plant Genotype | IBR5 Protein Detection | Observed Bands (kD) |
|---|---|---|
| Wild-type | Present | ~30, ~25 |
| ibr5-1 mutant | Absent | None |
| ibr5-2 mutant | Reduced | ~30 (weak signal) |
The antibody revealed two distinct bands (~30 kD and ~25 kD) in wild-type plants, with the ~30 kD band corresponding to the predicted IBR5 protein size (28.7 kD) . This dual detection suggests post-translational modifications or alternative splicing of IBR5, as supported by subsequent studies .
The antibody has been instrumental in elucidating IBR5’s role in:
Auxin Signaling: IBR5 negatively regulates the SCF TIR1/AFBs pathway by promoting the degradation of Aux/IAA proteins, contrasting with most auxin-insensitive mutants .
ABA Signaling: IBR5 modulates ABA responses, with mutants showing reduced sensitivity to exogenous ABA .
Defense Responses: IBR5 stabilizes R proteins like CHS3 and interacts with HSP90/SGT1b complexes to regulate pathogen resistance .
While the IBR5 antibody has been critical for protein-level studies, its utility is limited by the availability of detailed epitope mapping and cross-reactivity data. Future research could explore:
IBR5 Function and Related Studies:
IBR5 encodes a dual-specificity MAPK phosphatase that functions as a positive regulator of plant responses to auxin and ABA. Recent research has revealed its critical role in plant immune responses, particularly in temperature-dependent defense mechanisms . IBR5 antibodies are essential research tools for:
Detecting and quantifying IBR5 protein levels in different tissues and conditions
Investigating protein-protein interactions, particularly with immune receptors like CHS3
Studying the role of IBR5 in R protein-mediated defense responses
Examining how IBR5 contributes to temperature stress responses
Exploring its function in hormone signaling pathways
Studies have demonstrated that IBR5 protein accumulates significantly in the chs3-1 mutant, suggesting it plays a role in stabilizing the CHS3 protein . Specific antibodies against IBR5 are therefore crucial for detecting these changes in protein abundance and understanding underlying mechanisms.
Proper validation is critical for ensuring experimental reliability when working with IBR5 antibodies:
Western blot validation:
Compare wild-type samples with ibr5 mutants (such as ibr5-3 or ibr5-7)
Look for a band of expected molecular weight that is absent or reduced in mutant samples
Liu et al. demonstrated this approach by showing IBR5 protein presence in wild-type plants, reduced levels in ibr5-7, and complete absence in ibr5-3
Immunoprecipitation validation:
Perform IP with the IBR5 antibody followed by Western blot analysis
Confirm the immunoprecipitated protein is recognized by other IBR5 antibodies
Verify protein identity through mass spectrometry when necessary
Genetic validation:
Use complementation lines expressing IBR5 in ibr5 mutant backgrounds
Confirm antibody signal reappears in these complementation lines
Use inducible expression systems to show correlation between gene expression and antibody signal
Based on established research practices and the available literature, include:
Positive controls:
Wild-type plant samples known to express IBR5
Recombinant IBR5 protein
Tissues from plants overexpressing IBR5 (such as lines with 35S:HA-Flag-IBR5)
Negative controls:
IBR5 knockout or null mutant samples (ibr5-3 shows no detectable IBR5 protein)
Pre-immune serum (for polyclonal antibodies)
Isotype controls (for monoclonal antibodies)
Secondary antibody-only controls
The study by Liu et al. effectively used the ibr5-3 mutant as a negative control, demonstrating complete absence of IBR5 protein, while the ibr5-7 mutant showed reduced IBR5 levels compared to wild-type .
While specific storage information for IBR5 antibodies is not detailed in the search results, standard antibody handling practices should be followed:
Storage recommendations:
Store at -20°C for long-term storage
For working solutions, maintain at 4°C for up to one month
Avoid repeated freeze-thaw cycles by preparing small aliquots
Consider adding glycerol (final concentration 30-50%) for stability
Handling guidelines:
Centrifuge antibody vials briefly before opening
Use sterile techniques when handling antibody solutions
Mix gently by inversion or gentle pipetting rather than vortexing
Allow refrigerated antibodies to equilibrate to room temperature before opening
Based on the available research:
IBR5 is expressed in various plant tissues but shows differential accumulation under stress conditions
Accumulation significantly increases in the chs3-1 mutant, suggesting regulation during defense responses
Expression may vary in response to temperature changes, particularly chilling conditions
IBR5 levels should be examined in both normal growth conditions and under specific stresses
Researchers should be prepared for potential variations in IBR5 expression levels depending on:
Plant developmental stage
Tissue type
Environmental conditions (particularly temperature)
Presence of pathogens or activation of defense responses
IBR5 antibodies are valuable tools for investigating temperature-sensitive immune pathways, particularly in the context of chilling sensitivity as described by Liu et al. :
Protein accumulation analysis:
Use Western blotting with IBR5 antibodies to monitor changes in IBR5 protein levels at different temperatures
Compare wild-type plants with temperature-sensitive mutants like chs3-1
Quantify IBR5 abundance during temperature shifts and correlate with defense marker expression
Protein complex dynamics:
Employ co-immunoprecipitation with IBR5 antibodies to isolate protein complexes under varying temperatures
Analyze how temperature affects interactions between IBR5 and partners like CHS3, HSP90, and SGT1b
Determine if cold treatment alters the composition or stability of these complexes
Liu et al. demonstrated that IBR5 forms a complex with CHS3, HSP90, and SGT1b that protects CHS3, particularly important under chilling conditions . Using IBR5 antibodies, researchers can further investigate how this protective complex responds to temperature fluctuations.
Based on approaches described in the literature :
Sample preparation:
Use freshly prepared plant tissue harvested under specific conditions (temperature, pathogen exposure)
Extract proteins in buffers that preserve native interactions (containing mild detergents)
Pre-clear lysates with protein A/G beads to reduce non-specific binding
Immunoprecipitation procedure:
Incubate cleared lysates with optimized amounts of IBR5 antibody
Capture antibody-protein complexes with protein A/G beads
Wash extensively to remove non-specifically bound proteins
Elute bound proteins for analysis by Western blotting or mass spectrometry
Experimental design:
Perform reciprocal co-IPs using both IBR5 antibodies and antibodies against suspected interaction partners
For transiently expressed proteins, use epitope tags as demonstrated with HA-Flag-IBR5 and Myc-tagged proteins
Include appropriate controls: IgG control, input samples, and lysates from mutant plants
Liu et al. successfully demonstrated IBR5-CHS3 interactions using co-IP approaches in both Arabidopsis protoplasts and N. benthamiana, showing that IBR5 interacted specifically with the TIR domain of CHS3 .
The search results indicate that IBR5 functions in both defense responses and auxin signaling pathways, with some evidence of separable roles :
Comparative protein interaction analysis:
Use IBR5 antibodies to immunoprecipitate protein complexes from plants treated with pathogens versus auxin
Compare the interactomes to identify shared versus pathway-specific interaction partners
Analyze how mutations in specific domains affect these distinct interactions
Functional domain studies:
Use domain-specific IBR5 antibodies to determine which regions mediate different interactions
Compare wild-type IBR5 with the catalytically inactive IBR5<sup>C129S</sup> to determine role of phosphatase activity
Liu et al. showed IBR5<sup>C129S</sup> only partially rescued chs3 ibr5 phenotypes, indicating phosphatase activity is important but not the only function
Pathway-specific activity assays:
Immunoprecipitate IBR5 from plants under different conditions using specific antibodies
Test phosphatase activity against different substrates (MPK12 for auxin signaling; potential defense pathway substrates)
Determine if IBR5's catalytic activity changes during defense versus hormone responses
Liu et al. reported that IBR5 exhibits holdase activity and physically associates with CHS3, HSP90 and SGT1b to form a protective complex :
Protein stability assays:
Use IBR5 antibodies to monitor CHS3 protein levels in wild-type versus ibr5 mutant plants
Perform pulse-chase experiments to examine protein turnover rates
Test whether IBR5's holdase function is separable from its phosphatase activity
Complex assembly analysis:
Employ size exclusion chromatography followed by Western blotting with IBR5 antibodies
Determine the stoichiometry and order of assembly of the IBR5-CHS3-HSP90-SGT1b complex
Identify which domains of IBR5 are critical for holdase versus phosphatase functions
Chaperone activity assays:
Use purified components and IBR5 antibodies to monitor protein aggregation
Test whether IBR5 prevents thermal denaturation of client proteins like CHS3
Compare holdase activity of wild-type IBR5 versus phosphatase-dead IBR5<sup>C129S</sup>
The search results indicate that IBR5 functions in multiple R protein-mediated defense pathways beyond CHS3, including SNC1, RPS4, and RPM1 :
Comparative immunoprecipitation:
Use IBR5 antibodies to pull down protein complexes from plants expressing different R proteins
Identify common versus R protein-specific components of these complexes
Determine if IBR5 interacts directly with multiple R proteins or via shared adaptor proteins
R-protein stabilization analysis:
Monitor R protein levels using specific antibodies in wild-type versus ibr5 mutant backgrounds
Test whether IBR5's effect on R protein stability is universal or specific to certain classes
Examine how environmental conditions affect these stabilization functions
Defense output measurements:
Correlate IBR5 protein levels (detected via antibodies) with expression of defense marker genes
Compare defense outputs across different R protein activation scenarios with or without functional IBR5
Determine whether IBR5's role is specific to certain defense signaling branches
When working with plant samples, several factors can influence IBR5 antibody performance:
Sample preparation challenges:
Plant tissues contain abundant polyphenols and other compounds that can interfere with antibody binding
Extraction buffers should include PVPP, PVP, or other additives to remove these interfering compounds
Protein degradation during extraction can reduce detectable IBR5 signal
Potential cross-reactivity:
IBR5 belongs to the dual-specificity phosphatase family, which may share conserved domains
Validate antibody specificity using ibr5 null mutants like ibr5-3 as demonstrated by Liu et al.
Consider using epitope-tagged versions of IBR5 with tag-specific antibodies for highest specificity
Recommended solutions:
Optimize extraction procedures for your specific plant tissue
Use freshly prepared samples whenever possible
Include protease inhibitors during all steps of protein isolation
Validate antibodies in your specific experimental system before proceeding to complex experiments
Emerging technologies offer new opportunities for studying IBR5 function:
Single-cell antibody-based approaches:
Single-cell Western blotting could reveal cell-to-cell variability in IBR5 expression
Flow cytometry with intracellular staining (similar to approaches described in reference ) could analyze IBR5 expression patterns across cell populations
Humanized antibody development:
Approaches similar to those described for rabbit monoclonal antibodies could be applied to generate high-affinity IBR5 antibodies
These might offer improved specificity and sensitivity for detecting low-abundance IBR5 protein
Structure-guided antibody engineering:
Similar to methodologies described in reference , structure-based approaches could generate antibodies specific to active versus inactive IBR5 conformations
This would allow researchers to monitor IBR5 activation states in different signaling contexts
Climate resilience research:
Given IBR5's role in temperature-dependent defense responses , antibodies could help elucidate mechanisms of plant adaptation to changing climates
Monitoring IBR5-CHS3 complex formation under varying temperature regimes might reveal temperature sensing mechanisms
Synthetic immunity engineering:
Understanding how IBR5 stabilizes multiple R proteins could inform efforts to engineer broad-spectrum disease resistance
Antibodies would be essential tools for monitoring the stability and function of engineered immune complexes
Systems biology approaches:
Integration of proteomic data (using IBR5 antibodies) with transcriptomic, metabolomic, and phenotypic datasets
This could provide a comprehensive view of IBR5's role in coordinating defense and development